Search Results - Wilhelm Huisinga

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Index analysis: An approach to understand signal transduction with application to the EGFR signalling pathway. by Jane Knöchel, Charlotte Kloft, Wilhelm Huisinga

    Published in PLoS Computational Biology (2024-02-01)
    Get full text
    Article


  2. 2

    Cell‐level systems biology model to study inflammatory bowel diseases and their treatment options by Sabine Stübler, Charlotte Kloft, Wilhelm Huisinga

    Get full text
    Article


  3. 3

    Drug-class specific impact of antivirals on the reproductive capacity of HIV. by Max von Kleist, Stephan Menz, Wilhelm Huisinga

    Published in PLoS Computational Biology (2010-03-01)
    Get full text
    Article


  4. 4

    Deriving mechanism‐based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarin by Undine Falkenhagen, Jane Knöchel, Charlotte Kloft, Wilhelm Huisinga

    Get full text
    Article


  5. 5

    Three-component contour dynamics model to simulate and analyze amoeboid cell motility in two dimensions by Daniel Schindler, Ted Moldenhawer, Carsten Beta, Wilhelm Huisinga, Matthias Holschneider

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  6. 6

    Estimating HIV-1 fitness characteristics from cross-sectional genotype data. by Sathej Gopalakrishnan, Hesam Montazeri, Stephan Menz, Niko Beerenwinkel, Wilhelm Huisinga

    Published in PLoS Computational Biology (2014-11-01)
    Get full text
    Article


  7. 7

    Three-component contour dynamics model to simulate and analyze amoeboid cell motility in two dimensions. by Daniel Schindler, Ted Moldenhawer, Carsten Beta, Wilhelm Huisinga, Matthias Holschneider

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  8. 8

    Spontaneous transitions between amoeboid and keratocyte-like modes of migration by Ted Moldenhawer, Eduardo Moreno, Daniel Schindler, Sven Flemming, Matthias Holschneider, Wilhelm Huisinga, Sergio Alonso, Carsten Beta

    Get full text
    Article


  9. 9

    Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing—A Translational Example for Intensive Care Units by Ferdinand Anton Weinelt, Miriam Songa Stegemann, Anja Theloe, Frieder Pfäfflin, Stephan Achterberg, Lisa Schmitt, Wilhelm Huisinga, Robin Michelet, Stefanie Hennig, Charlotte Kloft

    Published in Pharmaceutics (2021-12-01)
    Get full text
    Article


  10. 10

    A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non‐small cell lung cancer patients by Francis Williams Ojara, Andrea Henrich, Nicolas Frances, Yomna M. Nassar, Wilhelm Huisinga, Niklas Hartung, Kimberly Geiger, Stefan Holdenrieder, Markus Joerger, Charlotte Kloft

    Get full text
    Article


  11. 11

    Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies by Anna Mueller-Schoell, Lena Klopp-Schulze, Robin Michelet, Madelé van Dyk, Thomas E. Mürdter, Matthias Schwab, Markus Joerger, Wilhelm Huisinga, Gerd Mikus, Charlotte Kloft

    Published in Pharmaceuticals (2021-02-01)
    Get full text
    Article


  12. 12

    Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review by Alix Démaris, Ella S. K. Widigson, Johan F. K. F. Ilvemark, Casper Steenholdt, Jakob B. Seidelin, Wilhelm Huisinga, Robin Michelet, Linda B. S. Aulin, Charlotte Kloft

    Published in Pharmaceutics (2022-09-01)
    Get full text
    Article


  13. 13

    Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics by David Busse, Philipp Simon, David Petroff, Christoph Dorn, Lisa Schmitt, Davide Bindellini, Alexander Kratzer, Arne Dietrich, Markus Zeitlinger, Wilhelm Huisinga, Robin Michelet, Hermann Wrigge, Charlotte Kloft

    Published in Pharmaceutics (2021-08-01)
    Get full text
    Article


  14. 14

    Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients by Viktoria Stachanow, Uta Neumann, Oliver Blankenstein, Nele Alder-Baerens, Davide Bindellini, Peter Hindmarsh, Richard J. Ross, Martin J. Whitaker, Johanna Melin, Wilhelm Huisinga, Robin Michelet, Charlotte Kloft

    Published in Pharmaceuticals (2023-03-01)
    Get full text
    Article


  15. 15

    Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill Patients by Uwe Liebchen, Marian Klose, Michael Paal, Michael Vogeser, Michael Zoller, Ines Schroeder, Lisa Schmitt, Wilhelm Huisinga, Robin Michelet, Johannes Zander, Christina Scharf, Ferdinand A. Weinelt, Charlotte Kloft

    Published in Antibiotics (2021-04-01)
    Get full text
    Article


  16. 16

    Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach by Robin Michelet, Davide Bindellini, Davide Bindellini, Johanna Melin, Johanna Melin, Uta Neumann, Oliver Blankenstein, Wilhelm Huisinga, Trevor N. Johnson, Martin J. Whitaker, Richard Ross, Richard Ross, Charlotte Kloft

    Published in Frontiers in Pharmacology (2023-01-01)
    Get full text
    Article


  17. 17

    Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision... by Ferdinand Anton Weinelt, Miriam Songa Stegemann, Anja Theloe, Frieder Pfäfflin, Stephan Achterberg, Franz Weber, Lucas Dübel, Agata Mikolajewska, Alexander Uhrig, Peggy Kiessling, Wilhelm Huisinga, Robin Michelet, Stefanie Hennig, Charlotte Kloft

    Published in Antibiotics (2022-06-01)
    Get full text
    Article


Search Tools: